1. Home
  2. SLNH vs TXMD Comparison

SLNH vs TXMD Comparison

Compare SLNH & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soluna Holdings Inc.

SLNH

Soluna Holdings Inc.

N/A

Current Price

$1.19

Market Cap

271.5M

Sector

Technology

ML Signal

N/A

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.16

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNH
TXMD
Founded
1961
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
271.5M
24.3M
IPO Year
2005
2012

Fundamental Metrics

Financial Performance
Metric
SLNH
TXMD
Price
$1.19
$2.16
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
9.0M
32.8K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
80.41
73.68
EPS
N/A
0.02
Revenue
$38,021,000.00
$1,761,000.00
Revenue This Year
$55.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$106.00
Revenue Growth
80.49
35.25
52 Week Low
$0.59
$0.99
52 Week High
$5.14
$2.95

Technical Indicators

Market Signals
Indicator
SLNH
TXMD
Relative Strength Index (RSI) 47.05 45.47
Support Level $1.08 $1.95
Resistance Level $1.41 $2.15
Average True Range (ATR) 0.09 0.08
MACD 0.01 -0.01
Stochastic Oscillator 41.38 18.79

Price Performance

Historical Comparison
SLNH
TXMD

About SLNH Soluna Holdings Inc.

Soluna Holdings Inc is a U.S.-based company engaged in the development and operation of data centers powered by renewable energy. The company utilizes excess or curtailed energy from renewable sources to support high-performance computing applications, including cryptocurrency mining, artificial intelligence, and machine learning. Its business model focuses on converting underutilized renewable energy into computing resources through co-located data center infrastructure.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

Share on Social Networks: